drugset / Trial / NCT01450579
A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This trial is to investigate the clinically recommended dosage for ASP7373 based on the comparison of the immunogenicity and safety among the three doses of ASP7373 in healthy adults.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP7373 | Unknown | — | Other |
Indications
No indication recorded.